85 related articles for article (PubMed ID: 2516481)
1. [The hormonal profile in the polycystic ovary syndrome].
Donát J; Kohoutek M; Donátová N; Lacinová V
Cesk Gynekol; 1989 Nov; 54(9):684-8. PubMed ID: 2516481
[No Abstract] [Full Text] [Related]
2. Hormonal correlations in the polycystic ovary syndrome.
Messina M; Milani P; Gentile L
Boll Soc Ital Biol Sper; 1986 Jan; 62(1):31-5. PubMed ID: 3087390
[No Abstract] [Full Text] [Related]
3. [Circulating levels of LH, FSH and basal steroids in subjects with polycystic ovary syndrome before and after wedge resection of the ovaries].
Ragucci N; Amato G; Izzo A
Arch Ostet Ginecol; 1981; 86(5-6):263-79. PubMed ID: 6819842
[No Abstract] [Full Text] [Related]
4. Mullerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics.
La Marca A; Orvieto R; Giulini S; Jasonni VM; Volpe A; De Leo V
Fertil Steril; 2004 Oct; 82(4):970-2. PubMed ID: 15482785
[TBL] [Abstract][Full Text] [Related]
5. The effects of buserelin on the hormonal states in PCOD.
Willemsen WN; Franssen AM; Rolland R; Vemer HM
Prog Clin Biol Res; 1986; 225():377-89. PubMed ID: 3097673
[No Abstract] [Full Text] [Related]
6. Hyperprolactinaemia in polycystic ovary syndrome.
Lunde O
Ann Chir Gynaecol; 1981; 70(4):197-201. PubMed ID: 6797343
[TBL] [Abstract][Full Text] [Related]
7. [Relation between hyperprolactinemia and polycystic ovary syndrome].
Hámori M; Szendei G; Kovács I; Somos P
Zentralbl Gynakol; 1987; 109(8):481-6. PubMed ID: 3111126
[TBL] [Abstract][Full Text] [Related]
8. [Stein-Leventhal syndrome. Personal cases].
Rapino P; Sabatino P; Della Lunga S; Marulli R
Minerva Med; 1982 Oct; 73(40):2793-800. PubMed ID: 6813772
[No Abstract] [Full Text] [Related]
9. [Ovarian wedge resection for polycystic ovary syndrome: analysis of 28 cases].
Zhu RL
Zhonghua Fu Chan Ke Za Zhi; 1985 Sep; 20(5):290-3, 319. PubMed ID: 3936686
[No Abstract] [Full Text] [Related]
10. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
11. [Effects of metformin on the plasminogen activator system, endocrine, metabolic profiles in patients with polycystic ovary syndrome and clomiphene resistant cases].
Song J; Shen H; Li J; Huang Z; Zhang Y
Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):86-9. PubMed ID: 11953071
[TBL] [Abstract][Full Text] [Related]
12. Effect of spironolactone on testosterone and LHRH responsiveness in women with polycystic ovarian disease.
Evron S; Yosef SM; Schenker JG; Diamant YZ
Isr J Med Sci; 1984 Jul; 20(7):630-3. PubMed ID: 6432730
[No Abstract] [Full Text] [Related]
13. [Relations between polycystic ovary and idiopathic hirsutism].
Montesanti F; Rama GP; Francia G; Adami S; Lo Cascio V
G Clin Med; 1988 Mar; 69(3):183-5. PubMed ID: 2971587
[No Abstract] [Full Text] [Related]
14. [Hyperthecosis and endocrinological study].
Nagai K; Ohshige T; Sakata M; Koike H; Mori N; Miyakawa I
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Apr; 42(4):365-8. PubMed ID: 2113560
[No Abstract] [Full Text] [Related]
15. [Reaction of follicle-stimulating and luteinizing hormone to synthetic luteinizing hormone in the Stein-Leventhal syndrome].
Vulkov I
Akush Ginekol (Sofiia); 1976; 15(6):459-62. PubMed ID: 797267
[No Abstract] [Full Text] [Related]
16. [Somatomedin and somatostatin in polycystic ovary syndrome].
Huber JC
Gynakol Rundsch; 1991; 31 Suppl 2():66-8. PubMed ID: 1686431
[No Abstract] [Full Text] [Related]
17. The androgenic profile of women with non-insulin-dependent diabetes mellitus.
Tok EC; Ertunc D; Evruke C; Dilek S
J Reprod Med; 2004 Sep; 49(9):746-52. PubMed ID: 15493567
[TBL] [Abstract][Full Text] [Related]
18. Serum AMH, FSH, and LH levels in PCOS.
Georgopoulos NA; Saltamavros AD; Decavalas G; Piouka A; Katsikis I; Panidis D
Fertil Steril; 2010 Feb; 93(3):e13; author reply e14. PubMed ID: 20060523
[No Abstract] [Full Text] [Related]
19. [Menometrorrhagia: to whom, why, on which criteria to propose a hormonal exploration?].
Brailly-Tabard S; Trabado S; Khallouf O
J Gynecol Obstet Biol Reprod (Paris); 2008 Dec; 37 Suppl 8():S329-33. PubMed ID: 19268210
[TBL] [Abstract][Full Text] [Related]
20. Role of dehydroepiandrosterone sulfate as a prehormone for ovarian steroidogenesis.
Haning RV; Austin CW; Carlson IH; Kuzma DL; Zweibel WJ
Obstet Gynecol; 1985 Feb; 65(2):199-205. PubMed ID: 3155830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
